Anti-colitic efficacy of SC-41930 in colitic cotton-top tamarins.

Agents Actions

Marmoset Research Center, Oak Ridge (MARCOR), Oak Ridge Assoc. Univ., TN.

Published: January 1994

To evaluate anti-colitic efficacy, eight cotton-top tamarins (CTTs) with histologically confirmed persistent active colitis were given the anti-inflammatory agent SC-41930 (10 mg/kg BW by gavage BID) for eight weeks. Colonic endoscopy and biopsy observations, CBCs and clinical chemistries, and stool consistency were evaluated pre-, mid-, and posttreatment. Colitic activity was graded histologically from A1 (mild) to A5 (severe); results varied among the seven animals that completed the study: five improved, one worsened, and one was unchanged. Serum enzyme levels were significantly reduced with treatment. Stool condition remained puddly throughout treatment and body weights did not vary from pretreatment levels. However, SC-41930 produced histological evidence (reduced numbers of polymorphonuclear cells) of anti-colitic efficacy over an eight-week treatment period in CTTs with persistent active colitis. These results support the use of the CTT colitis model to evaluate efficacy of therapeutic agents and provide useful predictive information to aid in the medical management of human IBD.

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF01972713DOI Listing

Publication Analysis

Top Keywords

anti-colitic efficacy
12
cotton-top tamarins
8
persistent active
8
active colitis
8
efficacy sc-41930
4
sc-41930 colitic
4
colitic cotton-top
4
tamarins evaluate
4
evaluate anti-colitic
4
efficacy cotton-top
4

Similar Publications

Article Synopsis
  • Water-soluble arabinoxylan and water-soluble fibre from wheat bran (WB) have shown anti-colitic effects in mice, with a focus on understanding the impact of both soluble and insoluble fractions of WB on inflammatory bowel disease (IBD).
  • In an experiment, mice were fed different treatments including a control, a DSS (inducing IBD) group, and groups receiving water-insoluble (WBI) and water-soluble (WBS) fractions of WB, revealing that WBI significantly reduced inflammation and gut tissue damage compared to the DSS group.
  • The study indicates that WBI helps maintain a healthier gut microbiota while showing promise for further research into its mechanisms and active components, especially concerning the gut bacteria
View Article and Find Full Text PDF

Amitriptyline, a pleiotropic tricyclic antidepressant, possesses anti-oxidant and anti-inflammatory properties. Despite its diverse benefits, the specific effects of amitriptyline on IBD are not yet well defined. To explore this, we utilized a DSS-induced colitis model to examine the anti-inflammatory effects of amitriptyline and the underlying mechanisms by which it operates.

View Article and Find Full Text PDF

Ulcerative Colitis (UC) is a chronic idiopathic inflammatory bowel disease in which the colon's lining becomes inflamed. Exploring herbal remedies that can recover mucosal damage is becoming popular in UC. The study aims to investigate the probable colo-protective effect of a natural isoflavone, genistein (GEN), and/or a drug, sulfasalazine (SZ), against acetic acid (AA)-induced UC in rats, in addition to exploring the possible underlying mechanisms.

View Article and Find Full Text PDF

Dapsone (DpS) is an antimicrobial and antiprotozoal agent, especially used to treat leprosy. The drug shares a similar mode of action with sulfonamides. Additionally, it possesses anti-inflammatory activity, useful for treating autoimmune diseases.

View Article and Find Full Text PDF

Ulcerative colitis is a recurrent inflammatory illness of the colon with an elevated risk of developing colon cancer. The drugs presently used to treat UC cause adverse effects and are limited to symptomatic treatments. To overcome these constraints, naturally derived novel alternative therapies are being tested.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!